Evidence map›Paper›PMID 42235094›Full record

ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2026

DICER-driven regulation of lipid metabolism and macrophage-adipocyte crosstalk in partial lipodystrophy.

Andréa L Rocha, Rhaissa Godoi, Tanes Imamura de Lima, Diogo de Moraes, Bruna Brasil Brandão, Antonio F M Pinto, Heloísa Antoniella Braz-de-Melo, Felipe Corrêa da Silva, Tiago Tomazini Gonçalves, Letícia de Souza Figueiredo and 10 more

Abstract read
In one paragraph

Article in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Andréa L RochaDepartment of Biochemistry and Tissue Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil; Program in Genetics and Molecular Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil; Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA.
Rhaissa GodoiDepartment of Biochemistry and Tissue Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil; Program in Genetics and Molecular Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil.
Tanes Imamura de LimaObesity and Comorbidities Research Center (OCRC), Universidade Estadual de Campinas, Campinas, SP, Brazil.
Diogo de MoraesDepartment of Biochemistry and Tissue Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil; Program in Genetics and Molecular Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil.
Bruna Brasil BrandãoSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Antonio F M PintoClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA; Mass Spectrometry Core for Proteomics and Metabolomics, The Salk Institute for Biological Studies, La Jolla, CA, USA.
Heloísa Antoniella Braz-de-MeloDepartment of Cell Biology, Institute of Biological Sciences, Universidade de Brasilia, Brasilia, DF, Brazil.
Felipe Corrêa da SilvaProgram in Genetics and Molecular Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil.
Tiago Tomazini GonçalvesDepartment of Pharmacology, Faculty of Medical Sciences, Universidade Estadual de Campinas, Campinas, SP, Brazil.
Letícia de Souza FigueiredoDepartment of Biochemistry and Tissue Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil; Program in Morphofunctional and Molecular Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil.
João Pedro MazziDepartment of Biochemistry and Tissue Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil; Program in Morphofunctional and Molecular Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil.
Niedson Correia de Lima JuniorDepartment of Biochemistry and Tissue Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil.
Safira Maria Leite SousaDepartment of Biochemistry and Tissue Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil.
Josiane Erica MiyamotoDepartment of Biochemistry and Tissue Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil.
Luiz Osório LeiriaDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil; Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
Jan-Wilhelm KornfeldFunctional Genomics and Metabolism Research Unit, Institute of Biochemistry and Molecular Biology, Faculty of Science, University of Southern Denmark, Odense, Denmark; Novo Nordisk Foundation Center for Adipocyte Signaling, University of Southern Denmark, Odense, Denmark.
Kelly Grace MagalhãesDepartment of Cell Biology, Institute of Biological Sciences, Universidade de Brasilia, Brasilia, DF, Brazil.
Pedro Manoel Moraes-VieiraProgram in Genetics and Molecular Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil; Obesity and Comorbidities Research Center (OCRC), Universidade Estadual de Campinas, Campinas, SP, Brazil; Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil; Experimental Medicine Research Cluster (EMRC), Universidade Estadual de Campinas, Campinas, SP, Brazil.
Alan SaghatelianClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA; Mass Spectrometry Core for Proteomics and Metabolomics, The Salk Institute for Biological Studies, La Jolla, CA, USA.
Marcelo A MoriDepartment of Biochemistry and Tissue Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil; Program in Genetics and Molecular Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil; Obesity and Comorbidities Research Center (OCRC), Universidade Estadual de Campinas, Campinas, SP, Brazil; Program in Morphofunctional and Molecular Biology, Institute of Biology, Universidade Estadual de Campinas, Campinas, SP, Brazil; Experimental Medicine Research Cluster (EMRC), Universidade Estadual de Campinas, Campinas, SP, Brazil. Electronic address: morima@unicamp.br.

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Alan Saghatelian · 1985 to 2026
$82.8M
Regulation of the biosynthesis of a novel class of anti-diabetic lipidsR01DK106210 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KAHN, BARBARA B., SAGHATELIAN, ALAN · 2016 to 2024
$6.6M
A Hybrid Quadrupole-Orbitrap LC/MSS10OD021815 · OD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI SAGHATELIAN, ALAN · 2016 to 2016
$580k
NCI NIH HHS P30 CA014195NIDDK NIH HHS R01 DK106210NIH HHS S10 OD021815
6 · The paper itself

Abstract

Partial lipodystrophy is characterized by abnormal fat distribution, impaired thermogenesis, systemic inflammation, and diminished DICER1 expression in adipose tissue. Using adipocyte-specific Dicer1-deficient murine models to mimic lipodystrophy, we identified early metabolic and inflammatory alterations associated with the onset of partial lipodystrophy. DICER deficiency in adipocytes impaired lipid metabolism, leading to increased release of saturated lipids and triglycerides into the medium while reducing the biosynthesis of anti-inflammatory lipids. These changes promoted a pro-inflammatory environment by inducing macrophages to release IL-1β. In parallel, both adipocyte-autonomous DICER deficiency and the resulting inflammatory environment impaired adipocyte thermogenic capacity. Lipidomic analyses revealed reduced levels of docosahexaenoic acid (DHA) and other polyunsaturated fatty acids (PUFAs) in Dicer1-deficient adipocytes, accompanied by increased expression of genes encoding CYP450 enzymes linked to lipid degradation, and reduced DHA biosynthesis. Co-culture experiments confirmed that Dicer1-deficient adipocytes exacerbate macrophage-driven pro-inflammatory profile and thermogenic gene suppression. Notably, DHA supplementation mitigated the pro-inflammatory response triggered by conditioned media from Dicer1-deficient adipocytes. These findings reveal a critical role for adipocyte DICER in regulating lipid metabolism, macrophage-adipocyte interactions, and thermogenic function, offering new insights into molecular mechanisms driving metabolic dysfunction and chronic inflammation associated with partial lipodystrophy.

Indexed as

AdipocytesCell CommunicationDEAD-box RNA HelicasesLipid MetabolismLipodystrophyMacrophagesRibonuclease IIIAnimalsCoculture TechniquesDocosahexaenoic AcidsInflammationMiceMice, KnockoutThermogenesisDEAD-box RNA HelicasesDicer1 protein, mouseDocosahexaenoic AcidsRibonuclease IIIAdipocyteDICERLipidomicsLipodystrophyMacrophageThermogenesis

Identifiers

PMID42235094
PMCPMC13359648

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.